Peer-delivered Brief Motivational Interviewing Via Instant Messaging Interaction in Reducing the Drug Abuse Among Youth
The Medical Peer-delivered Intervention of Brief Motivational Interviewing Via Instant Messaging Interaction in Reducing the Drug Abuse Among Youth in Hong Kong: A Randomized Controlled Trial
1 other identifier
interventional
134
1 country
1
Brief Summary
This is a two-arm, parallel-group, randomized controlled trial with an allocation ratio 1:1, by comparing the 12-month drug abuse reduction between the youth drug abusers who are individually randomized to participate in the intervention group receiving medical peer-delivered intervention of interactive brief motivational interviewing via instant messaging communication and those in the control group receiving general health information.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMay 4, 2022
April 1, 2022
1.4 years
December 11, 2020
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in drug consumption at 12 months comparing to that at baseline
The participants' changes in drug consumption between baseline and 12 months follow-up measured using a structured-questionnaire gathering the frequency and categoties of drug consumption in the past 30 days. The more frequencies and the more kinds of drug used indicating the higher consumption of drug abuse.
12 month
Secondary Outcomes (9)
Changes in drug consumption at 6 month comparing to that at baseline
6 month
30 days self-reported drug abstinence at 6 months
6 month
30 days self-reported drug abstinence at 12 months
12 month
Changes in relapse risk among the quitters at 6 months comparing to that at baseline
6 month
Changes in relapse risk among the quitters at 12 months comparing to that at baseline
12 month
- +4 more secondary outcomes
Study Arms (2)
Brief MI interaction via instant communication
EXPERIMENTALThe interaction communication using brief motivational interviewing will be applied via the chatting function of instant messaging apps (e.g., WhatsApp, WeChat). The intervention will last for 6 month with a frequency of at least twice a week.
General health information
PLACEBO COMPARATORThe subjects will receive general health information via SMS, such as "do physical exercise for at least 30 min per week will keep you healthy" for 6 month with a frequency of least twice a week.
Interventions
Telephone peer counselling+referral to treatment if required+The interaction communication using brief motivational interviewing via the chatting function of instant messaging apps (e.g., WhatsApp, WeChat). The intervention will last for 6 month with a frequency of at least twice a week.
Telephone peer counselling+referral to treatment if required+general health information via SMS, such as "do physical exercise for at least 30 min per week will keep you healthy" for 6 month with a frequency of least twice a week.
Eligibility Criteria
You may qualify if:
- aged ≤ 25 years;
- report taking drugs within the past 30 days;
- be able to speak Cantonese and read traditional Chinese;
- accept to received counseling use messaging apps (such as WhatsApp, WeChat, and SMS text messenger);
- have verbally consented to join the follow-up intervention
You may not qualify if:
- have acute psychosis or other mental problems,
- are undergoing other drug abuse recovery treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Denise Shuk Ting Cheung, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2020
First Posted
December 17, 2020
Study Start
March 1, 2021
Primary Completion
August 1, 2022
Study Completion
December 1, 2023
Last Updated
May 4, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After the project is completed and the results of the project have been published.
- Access Criteria
- Request could be sent to Principal Investigator (william3@hku.hk)
The relevant anonymized patient-level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.